<DOC>
	<DOCNO>NCT02554565</DOCNO>
	<brief_summary>Quantification follow-up circulate tumoral DNA serum and/or plasma patient cervical cancer compare early detection minimal metastatic disease .</brief_summary>
	<brief_title>Nnovation Standard Identification Insertional HPV Mutations Target Therapeutic Genes Cervical Cancer : Towards Development Personalized Biomarkers Clinical Oncology</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1 . Patient cervical cancer , stage , antitumoral treatment . 2 . Age â‰¥ 18 year . 3 . Patient information signature inform consent her/his legal representative . 4 . Patient give her/his agreement second biopsy diagnosis first one perform outside center cryopreserved . 1 . Person deprive liberty supervision . 2 . Inability attend schedule followup visit psychological , sociological geographical reason .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Patients cervical cancer</keyword>
</DOC>